loop diuret chronic renal insuffici continu infus efficaci bolu therapi object hypothesi continu low-dos infus loop diuret efficaci convent intermitt bolu therapi patient sever chronic renal insuffici cri design clinic trial subject control set gener clinic research center indiana univers hospit indianapoli indiana patient eight adult volunt sever stabl cri mean creatinin clearanc ml/ rang ml/ outpati nephrolog clinic indiana univers medic center intervent admiss diuret drug patient mmol/d sodium mmol/d potassium metabol diet patient intraven dose bumetanid bolu dose hour total dose continu infus sodium balanc re-establish patient altern studi limb patient phase studi measur result compar amount bumetanid urin studi period infus microgram microgram differ microgram CI microgram continu infus net sodium excret infus mmol mmol differ mmol CI mmol mmol patient episod drug-induc myalgia continu infus patient bolu therapi conclus patient sever cri continu intraven infus bumetanid effect toxic convent intermitt bolu therapi continu administr use patient sever cri adequ natriuresi evid drug toxic standard diuret dose regimen similar benefit diuretic-resist patient cardiac hepat diseas studi patient 